Up Strategic Wealth Investment Advisors LLC Gilead Sciences, Inc. Transaction History
Up Strategic Wealth Investment Advisors LLC
- $133 Billion
- Q3 2025
A detailed history of Up Strategic Wealth Investment Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Up Strategic Wealth Investment Advisors LLC holds 4,457 shares of GILD stock, worth $553,069. This represents 0.4% of its overall portfolio holdings.
Number of Shares
4,457
Previous 4,465
0.18%
Holding current value
$553,069
Previous $495 Million
6.51%
% of portfolio
0.4%
Previous 0.39%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
2,368Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...